The Szent-Gyorgyi Prize for Progress in Cancer Research is a prestigious scientific award established by the National Foundation for Cancer Research(NFCR)—a leading cancer research charitable organization in the United States that is committed to supporting scientific research and public education relating to the prevention,early diagnosis,better treatments,and ultimately,a cure for cancer.Each year,the Szent-Gyorgyi Prize honors an outstanding researcher,nominated by colleagues or peers,who has contributed outstanding,significant research to the fight against cancer,and whose accomplishments have helped improve treatment options for cancer patients.The Prize also promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments.This report highlights the pioneering work led by the 2015 Prize winner,Dr.Frederick Alt.Dr.Alt's work in the area of cancer genetics over four decades has helped to shape the very roots of modern cancer research.His work continues to profoundly impact the approaches that doctors around the globe use to diagnose and treat cancer.In particular,his seminal discoveries of gene amplification and his pioneering work on molecular mechanisms of DNA damage repair have helped to usher in the era of genetically targeted therapy and personalized medicine.
展开▼
